GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Anti-tumor potential of temperature-sensitive p53 mutants

$422,360
Jiandong Chen · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA

Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection

$422,216
Marc D Porter · University Of Utah · U01 · FY2012 · CA

Improved Staging of Pancreatic Cancer

$422,108
Ralph Weissleder · Dana-Farber Cancer Inst · P50 · FY2009 · CA

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas

$422,074
Peter J Allen · Duke University · R01 · FY2023 · CA

Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA

$421,996
Howard S Hochster · New York University School Of Medicine · R01 · FY2008 · CA

Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer

$421,992
Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA

Targeting Dectin-2 on Tumor-associated Macrophages for the Treatment of Cancer

$421,729
Edgar G. Engleman · Stanford University · R01 · FY2019 · CA

The role of entosis in human cancers

$421,726
Michael H. Overholtzer · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Feasiblity Analysis of a Clinical Electroporation System

$421,720
Ichor Medical Systems, Inc. · R44 · FY2003 · CA

Multifactor risk scores with susceptibility gene mutations to enhance risk assessment of pancreatic cancer

$421,706
Ann Laura Oberg · Mayo Clinic Rochester · R01 · FY2025 · CA

Developing ATAC-array as a novel epigenetic biomarker to guide personalized therapy in pancreatic cancer

$421,689
Steven D Leach · Dartmouth College · R21 · FY2022 · CA

Inhibition of pleiotrophin to combat pancreatic cancer metastasis

$421,685
Rolf A Brekken · Ut Southwestern Medical Center · R21 · FY2024 · CA

Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy

$421,611
Edgar G. Engleman · Stanford University · P01 · FY2022 · CA

Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy

$421,608
Edgar G. Engleman · Stanford University · P01 · FY2023 · CA

The structure and function of eukaryotic protein glycosylation enzymes

$421,585
Huilin Li · Van Andel Research Institute · R01 · FY2019 · CA

Tumor maintenance and development in mouse models

$421,514
Sloan-Kettering Institute For Cancer Res · U01 · FY2005 · CA

Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network

$421,253
Evan L Fogel · Indiana University Indianapolis · U01 · FY2017 · DK

Molecular mechanisms of Hedgehog receptor function

$421,192
Philip A Beachy · Stanford University · R01 · FY2017 · GM

Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia

$421,180
Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2021 · CA

Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia

$421,180
Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2020 · CA

Immunophenotype Integration for Monitoring T Cell Dynamics in Pancreatic Cancers

$421,042
Won Jin Ho · Johns Hopkins University · R21 · FY2021 · CA

T Cell Alternative p38 Activation Pathway

$420,768
Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Cancer, venous thromboembolic disease and tissue factor-bearing microparticles

$420,750
Bruce Furie · Beth Israel Deaconess Medical Center · R01 · FY2012 · HL

The Role of Carboxypeptidase E in Cancer

$420,686
Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

Genome topology in the filamentous fungus Neurospora crassa: organizing factors and impact on genome function

$420,483
Andrew David Klocko · University Of Colorado · R15 · FY2020 · GM